Pathological Complete Response in Locally Advanced Breast Cancer after Neoadjuvant Chemotherapy: Survival Outcome and Its Relevance as a Surrogate End Point

Background  Pathological complete response (pCR) to neoadjuvant chemotherapy has emerged as a reliable surrogate marker for improved survival in breast cancer (BC), but its role as a surrogate end point is still controversial. Aims and Objectives  The aim of the study is to investigate the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Reshu, Unnikrishnan, U. G., Keechilat, Pavithran, Rajanbabu, Anupama, Jose, Wesley, Vijaykumar, D. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075624/
https://www.ncbi.nlm.nih.gov/pubmed/33937135
http://dx.doi.org/10.1055/s-0040-1721238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075624/
https://www.ncbi.nlm.nih.gov/pubmed/33937135
http://dx.doi.org/10.1055/s-0040-1721238

Ejemplares similares